Investing.com - Novartis ADR reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
Novartis ADR announced earnings per share of $1.58 on revenue of $12.54. Analysts polled by Investing.com anticipated EPS of $1.56 on revenue of $12.92B.
Novartis ADR shares are down 11.06% from the beginning of the year and are trading at $77.80 , down-from-52-week-high.
Novartis ADR follows other major Healthcare sector earnings this month
Novartis ADR's report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar